Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression

Major depressive disorder (MDD) often begins during adolescence and is projected to become the leading cause of global disease burden by the year 2030. Yet, approximately 40 % of depressed adolescents fail to respond to standard antidepressant treatment with a selective serotonin reuptake inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Douglas G., Forrest, Lauren N., Shi, Xianfeng, Sung, Young-Hoon, Hellem, Tracy L., Huber, Rebekah S., Renshaw, Perry F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974294/
https://www.ncbi.nlm.nih.gov/pubmed/26907087
http://dx.doi.org/10.1007/s00726-016-2194-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974294/
https://www.ncbi.nlm.nih.gov/pubmed/26907087
http://dx.doi.org/10.1007/s00726-016-2194-3

Ejemplares similares